Sometimes in investing we can find opportunities in sobering statistics. On a global scale, diabetes is reaching epidemic proportions with an estimated 285 million suffers worldwide. In America, nearly 24 million residents have been diagnosed and that number is expected to grow by an additional 12 million by 2020. Costs for diabetes care in the United States alone are estimated to be over $218 billion. Whatever the reason for this growing worldwide trend, (increasing sedentary lifestyle, food choices etc.) opportunities exist for investors in the companies that are working towards a cure or treat diabetes. (Perform a thorough checkup to uncover a medical stock with a clean bill of health. To learn more, see Investing In The Healthcare Sector.)

IN PICTURES: 6 Hot Careers With Lots Of Jobs

Long-Term Trend
The National Institute of Health estimates that obesity and related complications such as diabetes are our nation's chief health concern. There are nearly 133 million Americans that are currently considered overweight. This puts them at risk for the quickly growing Adult Onset or Type II Diabetes. The trend is a worldwide phenomenon. The World Health Organization research shows that more than 1 billion adults are overweight and at least 300 million of them clinically obese. As the world moves towards less physical activity and increased consumption of nutritionally deficient foods with higher levels of sugar and saturated fats, obesity rates and its complications will continue to rise, globally. This increase is often faster in developing countries. India is projected to have the most diabetes cases globally by the end of 2025.

A Portfolio Play
As we live longer, healthcare as a long-term trend makes sense despite the recent shake-ups regarding healthcare reform. Broad based exchange traded funds such as the Health Care Select Sector SPDR (NYSE:XLV) or the iShares Dow Jones U.S. Pharmaceuticals (NYSE:IHE) are good ways to play the sector. Since the HealthShares specific funds are no longer traded, investors wanting diabetes exclusive exposure need to look at individual companies. Here are a few picks.

One of the tragic effects of diabetes is the potential for kidney failure. Millions of people around the world suffer from this condition. Both DaVita (NYSE:DVA) and Fresenius Medical Care AG (NYSE:FMS) own and operate kidney dialysis centers. DaVita primarily focuses on the United States, while Fresenius operates around the world. Fresenius is also one of the chief producers of heparin, a blood thinner used in the dialysis.

Medical Devices
The diabetes sub-sector is the largest market for medical devices, growing from $12.4 billion in 2000 to current levels of nearly $27 billion today. Investors can play the device angle through several avenues from syringe manufacturers like Retractable Technologies (NYSE:RVP) and West Pharmaceutical (NYSE:WST), glucose monitors through Becton; Dickinson and Company (NYSE:BDX) or cutting edge insulin pumps through Medtronic (NYSE:MDT).

Diabetes Drugs
While there are several new therapy's in the works for diabetes care, insulin still remains at the bread and butter of the industry. Novo Nordisk (NYSE:NVO) became one of the first manufacturers of insulin in 1923 and currently supplies more than half of the worlds dosage. The company represents a pure drug player in the diabetes ring without the biotech stock risk.

The Bottom Line
Sadly, diabetes is quickly becoming a global epidemic. Nearly 300 million people suffer from the disease worldwide. As inactivity and high fat diets continue to seep into our lifestyles, the problem will compound them selves. Within these grim statistics, investors can find opportunities with the companies that are fighting this epidemic. The previous stocks represent a good starting point for further research. (Don't assume you're insured. Find out what you can expect from this healthcare program. For further reading, see What Does Medicare Cover?)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

Related Articles
  1. Mutual Funds & ETFs

    Why ETFs Are a Smart Investment Choice for Millennials

    Exchange-traded funds offer an investment alternative to cost-conscious millennials who want to diversify their portfolios with less risk.
  2. Stock Analysis

    Will J.C. Penney Come Back in 2016? (JCP)

    J.C. Penney is without a doubt turning itself around, but that doesn't guarantee the stock will respond immediately.
  3. Mutual Funds & ETFs

    Should Investors Take a BITE Out of This New ETF?

    ETF BITE offers a full menu of restaurants. Is now the right time to invest?
  4. Financial Advisors

    5 Things All Financial Advisors Should Know About ETFs

    Discover five things all financial advisors should know about ETFs, including when ETFs may be a better choice for your clients than mutual funds.
  5. Stock Analysis

    The Top 5 ETFs to Track the Nasdaq in 2016

    Check out five ETFs tracking the NASDAQ that investors should consider heading into 2016, including the famous PowerShares QQQ Trust.
  6. Investing

    Time to Bring Active Back into a Portfolio?

    While stocks have rallied since the economic recovery in 2009, many active portfolio managers have struggled to deliver investor returns in excess.
  7. Chart Advisor

    Now Could Be The Time To Buy IPOs

    There has been lots of hype around the IPO market lately. We'll take a look at whether now is the time to buy.
  8. Stock Analysis

    Allstate: How Being Boring Earns it Billions (ALL)

    A summary of what Allstate Insurance sells and whom it sells it to including recent mergers and acquisitions that have helped boost its bottom line.
  9. Chart Advisor

    Copper Continues Its Descent

    Copper prices have been under pressure lately and based on these charts it doesn't seem that it will reverse any time soon.
  10. Options & Futures

    Cyclical Versus Non-Cyclical Stocks

    Investing during an economic downturn simply means changing your focus. Discover the benefits of defensive stocks.
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>

You May Also Like

Trading Center